<DOC>
	<DOCNO>NCT00186121</DOCNO>
	<brief_summary>To evaluate antitumor activity , toxicity , effectiveness combination Arimidex Zoladex treatment premenopausal woman hormone receptor positive metastatic carcinoma breast .</brief_summary>
	<brief_title>Estradiol Suppression Treatment Metastatic Breast Cancer Premenopausal Women</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Anastrozole</mesh_term>
	<mesh_term>Goserelin</mesh_term>
	<criteria>Patients must histologically confirm , bidimensionally measurable , recurrent metastatic carcinoma breast progressive . All patient must female premenopausal . Premenopausal define either : ( 1 ) last menstrual period within 3 month , ( 2 ) posthysterectomy without bilateral oophorectomy FSH premenopausal range , , ( 3 ) tamoxifen within past 3 month , plasma estradiol premenopausal range . Patients must either positive estrogen and/or progesterone receptor determination IHC competitive binding assay metastatic disease , perform metastatic disease positive result primary breast cancer specimen . No prior treatment aromatase inhibitor inactivator . No prior treatment LH/RH agonist/antagonist . No adjuvant chemotherapy within 6 month study entry . Patients must ECOG performance status 0 , 1 , 2 . Patients must adequate bone marrow , hepatic , renal function define follow : Granulocytes &gt; 1500/mm^3 Platelets &gt; 100,000/mm^3 SGOT &lt; 2.5x upper limit normal Total bilirubin &lt; 1.5 mg/dL Patients central nervous system metastasis lymphangitic pulmonary metastasis eligible . Patients must receive chemotherapy hormonal therapy least 3 week prior enrollment . Patients may receive irradiation bony sit disease pain control prevention fracture , irradiate site ( ) NOT consider evaluable disease response . Patients pregnant lactate ineligible . Must use effective contraception childbearing potential . Patients must active malignancy breast cancer , situ carcinoma cervix , nonmelanomatous skin cancer past 5 year . No active , unresolved infection . All patient must give sign write informed consent .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>